heart disease Clinical Trials and Research
Also known as: cardiovascular disease, cardiac illness, coronary artery disease, heart failure, atherosclerosis, circulatory disease · ICD-10: I00-I99
Heart disease refers to a range of conditions affecting the heart's structure and function. Clinical trial research aims to improve prevention, diagnosis, and treatment for these diverse conditions, including new medications and devices. Find a Trial helps patients search for active studies exploring new ways to manage heart disease and improve heart health.
Common questions about heart disease clinical trials
Who can participate in heart disease clinical trials?
Eligibility criteria vary greatly by study, often considering age, specific heart condition, overall health, and other medical factors. Researchers ensure participant safety and study relevance by carefully defining who can join.
What are the different phases of clinical trials for heart disease?
Clinical trials for heart disease typically progress through phases 1 to 4. Early phases test safety and dosage, while later phases evaluate effectiveness and compare new treatments to existing ones.
Do clinical trials for heart disease cost money to participate?
Generally, study-related medical care and interventions in clinical trials are covered by the trial sponsor. However, participants may be responsible for routine medical care or travel expenses.
What are current research directions in heart disease clinical trials?
Current research, as seen on ClinicalTrials.gov and NIH RePORTER, explores new medications, medical devices, surgical techniques, and lifestyle interventions. Focus areas include heart failure, coronary artery disease, and arrhythmias.
What types of interventions are studied in heart disease trials?
Interventions include new drug therapies, advanced surgical procedures, innovative medical devices like pacemakers or stents, and lifestyle modifications such as diet and exercise programs. These are investigated to improve heart health outcomes.
Are there specific biomarkers relevant to heart disease clinical trials?
Yes, biomarkers like troponin, BNP, and cholesterol levels are often measured to assess heart damage, function, and risk factors. Researchers use these to monitor disease progression and treatment response, according to ClinicalTrials.gov.
What might prevent someone from joining a heart disease clinical trial?
Common exclusion criteria can include uncontrolled co-existing medical conditions, recent major cardiac events, pregnancy, or use of certain medications that could interfere with the study. These ensure participant safety and data integrity.
What are the potential benefits and risks of participating in heart disease trials?
Potential benefits include access to new treatments and close medical monitoring. Risks can involve side effects, unknown effectiveness, or the need for frequent visits. Information is available on ClinicalTrials.gov.
How to find a heart disease trial that fits you
- Describe your heart disease situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all heart disease trials →